PNC Financial Services Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$138K Buy
1,615
+26
+2% +$2.71K ﹤0.01% 2750
2026
Q2
$186K Buy
1,589
+233
+17% +$23.4K ﹤0.01% 2507
2026
Q1
$125K Buy
1,356
+744
+122% +$70K ﹤0.01% 2662
2025
Q4
$48.3K Sell
612
-650
-52% -$46.7K ﹤0.01% 3231
2025
Q3
$92.5K Buy
1,262
+817
+184% +$51.9K ﹤0.01% 2853
2025
Q2
$22.6K Sell
445
-8
-2% -$356 ﹤0.01% 3513
2025
Q1
$20.4K Buy
453
+282
+165% +$13.3K ﹤0.01% 3529
2024
Q4
$7.07K Sell
171
-52
-23% -$2.17K ﹤0.01% 3923
2024
Q3
$8.7K Buy
223
+132
+145% +$5.27K ﹤0.01% 3850
2024
Q2
$3.11K Sell
91
-46
-34% -$1.21K ﹤0.01% 4129
2024
Q1
$3.44K Buy
137
+96
+234% +$2.64K ﹤0.01% 4062
2023
Q4
$1.21K Buy
41
+26
+173% +$787 ﹤0.01% 4285
2023
Q3
$474 Hold
15
– – ﹤0.01% 4468
2023
Q2
$388 Buy
+15
New +$399 ﹤0.01% 4612
2023
Q1
– Sell
-18
Closed -$351 – 4772
2022
Q4
$351 Hold
18
– – ﹤0.01% 4575
2022
Q3
$0 Hold
18
– – ﹤0.01% 4548
2022
Q2
$0 Buy
+18
New +$425 ﹤0.01% 4629

Other funds holding MIRM

PNC Financial Services Group's MIRM Position: Q3 2026 in Review

PNC Financial Services Group increased its Mirum Pharmaceuticals (MIRM) stake by 1.6% in Q3 2026, buying an estimated $2.71K and bringing the position to 1,615 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

PNC Financial Services Group first reported a position in MIRM in Q2 2022 and has held it in 17 quarters since. The position peaked at $186K in Q2 2026. 251 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • PNC Financial Services Group held 1,615 shares of Mirum Pharmaceuticals worth $138K as of Q3 2026.
  • PNC Financial Services Group bought 26 Mirum Pharmaceuticals shares in Q3 2026, an estimated $2.71K.
  • Mirum Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2750 holding.
  • PNC Financial Services Group first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • PNC Financial Services Group's Mirum Pharmaceuticals position peaked at $186K in Q2 2026.
  • 251 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.